AzTrials
AzTrials

Autism Spectrum DisorderTIPINCT04245306

Pilot Evaluation of a New Computerized Test for Pragmatic Inferences in Children with ASD

A study testing computerized test for pragmatic inferences in people with Autism Spectrum Disorder, run by Hôpital le Vinatier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the relevance of a new computerized test for pragmatic inferences (TIPi) in children aged 8 to 12 YO, presenting a typical development, autism spectrum disorders, another neurodevelopmental condition and attention-deficit/hyperactivity disorder. Read more about this study

Who is it for?
Ages 8 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
computerized test for pragmatic inferences
Could I receive a placebo?
No, everyone receives an active treatment
How many people
232 participants
Where
1 siteFrance
Study dates
7 Feb 2020to 4 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age between 8 and 12 years old
  • Native French speaker
  • Informed consent of the parents and children
  • [For ASD group] Diagnosis of ASD provided by a trained and entitled clinician
  • [For DLD group] Diagnosis of DLD provided by a trained and entitled clinician
  • [For ASD and DLD groups] IQ above 70
  • Intellectual efficiency within the norm (ITQ > 70), confirmed by objective results (psychometrics) in the participant's file, or collected if necessary within the framework of this study (using the WISC V);
  • Medical diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) by a competent professional, confirmed by a parental assessment (ADHD-RS-IV)

Who cannot join

  • Uncorrected visual impairment
  • Uncorrected auditory impairment
  • Motor disability preventing the use of a touch pad
  • [For the TD group] Diagnosis of any neurodevelopmental or psychiatric condition
  • [For ASD group] Diagnosis of language disorder of attention disorder (ADHD)
  • [For DLD group] Diagnosis of ASD or ADHD
  • [For ADHD group] Diagnosis of ASD or DLD

Trial locations and contacts

1 site in 1 country.

France1 site
  • Ch Le Vinatier

    Bron, 69678

Other trials in France

About this study

Official title: Pilot Evaluation of a New Computerized Test for Pragmatic Inferences in Children with Autism Spectrum Disorder Aged 8-12 Years Old

This study aims to evaluate the relevance of a new computerized test for pragmatic inferences (TIPi) in children aged 8 to 12 YO, presenting a typical development, autism spectrum disorders, another neurodevelopmental condition and attention-deficit/hyperactivity disorder.

Read the detailed description

By virtue of pragmatic inference-making, a listener can go above and beyond the linguistic meaning of the speaker's utterance in order to understand what the speaker intended to communicate. Such inferences allow the listener to understand inter alia irony, metaphor, indirect requests, scalar and ad-hoc implicatures. Autistic individuals have typically been described, by clinicians and language specialists, as tending towards having a literal understanding of language and as being deficient with respect to understanding a speaker's intended meaning, and these difficulties have a major impact on quality of life and social participation. Therefore, assessing these abilities seems essential, both for diagnosis purpose and to draw a clear description of an individual's functioning profile. Yet, no tool is available for children aged 8 to 12 in French. A new test named TIPi has been developed to resolve this issue. This new test is computerized and runs in a touch pad. The main goal of the present study is to evaluate the ability of the TIPi to discriminate autism spectrum disorders (ASD), attention-deficit/hyperactivity disorder (ADHD) children from typically developing (TD) children. Secondary goals are (i) to measure the typical development of these abilities in TD children in this age range, (ii) to assess the developmental link these skills might have with other cognitive of language abilities (mentalizing, cognitive flexibility, core language skills, central coherence), and (iii) to compare the pragmatic profile of ASD children with another neurodevelopmental condition: developmental language disorder, in order to test the relevance of this test for differential diagnosis.

Being tested
computerized test for pragmatic inferences
Keywords
pragmatic inferences, non-literal language, autism, attention-deficit, hyperactivity disorder, ADHD
Medical subject headings
Autism Spectrum Disorder, Autistic Disorder, Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • computerized test for pragmatic inferencesOther

    Computerized tests

Study groups in NCT04245306
Study groupRoleWhat they receive
Children with Autism Spectrum DisordersExperimentalA group of 25 children with autism spectrum disorders (ASD)
Receives: Other: computerized test for pragmatic inferences
Typically Developing childrenActive comparatorA larger group of 150 typically developing children (TD)
Receives: Other: computerized test for pragmatic inferences
Children with Developmental Language DisordersExperimentalA group of 25 children with developmental language disorders (DLD)
Receives: Other: computerized test for pragmatic inferences
children with attention-deficit/hyperactivity disorder (ADHD group)Experimental25 children with attention-deficit/hyperactivity disorder (ADHD group)
Receives: Other: computerized test for pragmatic inferences

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to TD children in the composite score of the TIPi.

    The dissociation between the developmental trajectories of these two groups will be assessed by comparing the coefficients of the linear regressions linking performance in the TIPi (composite score) and chronological age in these two groups.

    Measured: One day

Secondary outcomes (3)
  1. Sensitivity of the TIPi composite score (measuring pragmatic inferencing) to typical development in the targeted age range: 8 to 12 years oldin the targeted age range: 8 to 12 years old

    Sensitivity to age of the TIPi composite score is assessed by the alpha coefficient of the regression analysis linking the composite score to chronological age in the TD group.

    Measured: One day

  2. The TIPi composite score provides additional information compared to other cognitive assessments typically provided in the global assessment of children with ASD

    The predictive power of the best fitted multiple regression model explaining this measure by - jointly - performances in language task, mentalizing task, cognitive flexibility task, central coherence task and age (this predictive power being measured by the adjusted R2 of the model).

    Measured: One day

  3. Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to children with DLD in the composite score of the TIPi.

    The dissociation between the developmental trajectories of these two groups will be assessed by comparing the coefficients of the linear regressions linking performance in the TIPi (composite score) and chronological age in these two groups.

    Measured: One day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2020
  2. Study start7 Feb 2020
  3. Primary completion7 Feb 2020
  4. Study completion4 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Three groups of children are included to be compared, in order to test the primary and secondary hypothesis of this study : * A group of 25 children with autism spectrum disorders (ASD) * A larger group of 190 typically developing children (TD) * A group of 25 children with developmental language disorders (DLD) * A group of 25 children with attention-deficit/hyperactivity disorder (ADHD group)
Masking
None (open label)
Enrolment
232 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04245306
Sponsor's protocol ID
2019-A01721-56
Acronym
TIPI
Status last verified
Nov 2023
First submitted
17 Jan 2020
Last updated
28 Oct 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing computerized test for pragmatic inferences in people with Autism Spectrum Disorder, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to TD children in the composite score of the TIPi. (time frame: One day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in